Organ Preservation: Weekly Carboplatin & Taxol w/Concurrent RT for Locally Advanced Laryngeal & Hypopharyngeal CA

This study is ongoing, but not recruiting participants.

First Received: September 21, 2007 Last Updated: September 24, 2007 History of Changes

Sponsored by:	King Faisal Specialist Hospital & Research Center
Information provided by:	King Faisal Specialist Hospital & Research Center
ClinicalTrials.gov Identifier:	NCT00534729

Purpose

Organ Preservation: Weekly Carboplatin & Taxol w/concurrent RT for locally advanced laryngeal & Hypopharyngeal CA

Condition	Intervention
Laryngeal Neoplasms Hypopharyngeal Neoplasms	Drug: Weekly Carboplatin & Taxol w/concurrent RT

MedlinePlus related topics: Cancer

Drug Information available for: Paclitaxel Carboplatin

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Open Label, Single Group Assignment

Eligibility

Genders Eligible for Study:

Both

Criteria

Inclusion Criteria:

Patients with locally advanced laryngeal & Hypopharyngeal CA

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00534729

Locations

Saudi Arabia
KFSH&RC
Riyadh, Saudi Arabia, 1211

Sponsors and Collaborators

King Faisal Specialist Hospital & Research Center

Investigators

Principal Investigator:

Nasser Al-Rajhi, MD

KFSH&RC

More Information

No publications provided

Study ID Numbers:	RAC#0971-024
Study First Received:	September 21, 2007
Last Updated:	September 24, 2007
ClinicalTrials.gov Identifier:	NCT00534729 History of Changes
Health Authority:	United States: Institutional Review Board

Keywords provided by King Faisal Specialist Hospital & Research Center:

Organ Preservation
Carboplatin
Taxol

RT
laryngeal & Hypopharyngeal CA
Locally advanced laryngeal & Hypopharyngeal CA

Study placed in the following topic categories:

Otorhinolaryngologic Neoplasms
Otorhinolaryngologic Diseases
Laryngeal Carcinoma
Pharyngeal Neoplasms
Laryngeal Neoplasms
Antimitotic Agents
Carboplatin
Pharyngeal Diseases

Hypopharyngeal Neoplasms
Respiratory Tract Diseases
Paclitaxel
Head and Neck Neoplasms
Tubulin Modulators
Stomatognathic Diseases
Laryngeal Diseases
Antineoplastic Agents, Phytogenic

Additional relevant MeSH terms:

Respiratory Tract Neoplasms
Otorhinolaryngologic Neoplasms
Otorhinolaryngologic Diseases
Molecular Mechanisms of Pharmacological Action
Antineoplastic Agents
Mitosis Modulators
Pharyngeal Neoplasms
Laryngeal Neoplasms
Antimitotic Agents
Carboplatin
Pharyngeal Diseases
Pharmacologic Actions

Hypopharyngeal Neoplasms
Neoplasms
Neoplasms by Site
Respiratory Tract Diseases
Paclitaxel
Therapeutic Uses
Head and Neck Neoplasms
Tubulin Modulators
Stomatognathic Diseases
Laryngeal Diseases
Antineoplastic Agents, Phytogenic

ClinicalTrials.gov processed this record on May 07, 2009